BioCentury
ARTICLE | Clinical News

BioChaperone insulin combo: Phase Ib started

October 10, 2016 7:00 AM UTC

Adocia began a double-blind, double-dummy, 3-way crossover, German Phase Ib trial of subcutaneous BioChaperone Combo given before a meal on 3 consecutive days in 36 patients. The trial will compare Bi...